Low Level Laser Therapy
Advanced Dermatological Care Calibrated for Indian Skin & Hair
Low Level Laser Hair therapy effectively arrests hair fall. Visit dermatologist for hair in bangalore, Dr. Divya Sharma to restore your crowning glory.

MBBS, MD (Dermatology)

LLLT involves exposing the tissue to low levels of red and near-infrared
light and is known as “low level” because of its use of light at energy
densities that are much lower compared to conventional laser therapy that
is used for ablation, cutting, and thermally coagulating tissue. LLLT also
known as *“cold laser”* because the power density is much lower than those
with conventional lasers.
Clinical Protocol Steps
Personalized treatment roadmap tailored to individual skin and hair health.
Diagnostic Dermoscopy & Consultation
Comprehensive analysis of condition depth, triggers, and medical history.
Targeted Medical Procedure
Application of US-FDA cleared clinical lasers, peels, or medical therapies.
Barrier Repair & Long-Term Maintenance
Personalized post-treatment regimen to ensure lasting results and prevent recurrence.
Frequently Asked Questions
What are the uses of LLLT?+
LLLT has been used in all specialties in the medical world ranging from stroke, neurological and wound healing. LLLT is being increasingly used in Trichology for stimulation of new hair growth, reducing scalp inflammation and even reducing hair fall.
Is it safe or what are the side effects?+
It is one of the easiest to do the procedure as it is non invasive, low-discomfort and is an office time procedure. Improvement is reported in at least some users after 12 to 26 weeks of use, with reduced hair fall and noticeable hair growth. It is a very useful adjuvant treatment with other hair loss treatments that would definitely emphasize about the importance of regularity, which includes frequent appointments (twice a week) over a long duration (typically one year). At DSHS, we provide both basic and advanced form of low-level laser therapy at very reasonable prices in Whitefield and Marathahalli.
How does LLLT help in hair loss?+
Low level laser therapy stimulates hair follicles to reenter the growth phase from dormancy and prolongs the growth phase of the hair. It helps in preventing premature aging of the follicle. It may modestly improve hair density in some users. The hair growth cycle consists of three phases: growth (anagen phase), regression (catagen phase), resting (telogen phase) and shedding (exogen phase). Hair loss in androgenetic alopecia depends on a testosterone derivative in the skin, dihydrotestosterone (DHT). Low-level laser therapy is believed to increase blood flow in the scalp and stimulate metabolism in catagen or telogen follicles, resulting in the production of anagen hair. The photons of light act on cytochrome C oxidase leading to the production of adenosine triphosphate (ATP)which is converted to cyclic AMP in the follicle cells releasing energy and stimulating metabolic processes necessary for hair growth. Release of nitric oxide from cells leads to increased vascularisation to the scalp distributing nutrients and oxygen to the hair roots. Its effect on DHT has not been demonstrated.
Complementary Treatments & Cross-Specialties
Hollywood Carbon Peel→
Instant glow facial with laser skin rejuvenation
Acne & Pimples Care→
Targeted clinical protocols for active acne & cystic breakouts
Melasma & Pigmentation→
Advanced combination therapy for hormonal facial pigmentation
Hair Loss & GFC Therapy→
Growth factor concentrate therapy for hair regrowth
Laser Tattoo Removal→
Q-Switched laser ink clearance with low scarring risk
Keratosis Pilaris Care→
Medical smoothing for bumpy skin on arms and legs
References & Further Reading
Claims on this page have been reviewed against current peer-reviewed literature and clinical guidelines, including:
- Liu KH, et al. Comparative effectiveness of low-level laser therapy for adult androgenic alopecia: a systematic review and meta-analysis of randomized controlled trials. Lasers Med Sci. 2019. PubMed PMID: 30706177
- Kanti V, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men – short version. J Eur Acad Dermatol Venereol. 2018. PubMed PMID: 29178529
The information on this website is for general patient education only and is not a substitute for an in-person medical consultation, diagnosis or treatment. Treatment suitability and outcomes vary from person to person; no specific result is promised. Please consult a registered medical practitioner for advice on your condition.




